Now Reading
Alphabet’s AI unit Isomorphic inks drug discovery offers with Eli Lilly, Novartis for as much as $3B – Endpoints Information

Alphabet’s AI unit Isomorphic inks drug discovery offers with Eli Lilly, Novartis for as much as $3B – Endpoints Information

2024-01-07 12:20:00

Iso­mor­phic Labs, Al­pha­wager’s shut­ly watched AI begin­up, has signed its first phar­ma half­ner­ships, and can work with Eli Lil­ly and No­var­tis in offers that might be value $3 bil­lion, CEO Demis Has­s­abis ex­clu­sive­ly advised Finish­factors Information.

Since its discovered­ing in No­vem­ber 2021, Iso­mor­phic has fast­ly be­come a lead­ing fig­ure within the fast-grow­ing AI biotech house. The Al­pha­wager sub­sidiary is ap­ply­ing Google Deep­Thoughts’s bi­ol­o­gy re­search — par­tic­u­lar­ly its professional­tein-struc­ture pre­dict­ing mod­el Al­phaFold — to drug dis­cov­ery. Has­s­abis is CEO of Google Deep­Thoughts, the place he over­sees Al­pha­wager’s AI ef­forts, in addition to CEO of Iso­mor­phic, which now em­ploys about 90 peo­ple throughout its Lon­don head­quar­ters and an of­fice in Lau­sanne, Switzer­land.

Endpoints News

See Also

Unlock this text immediately by turning into a free subscriber.

You’ll get entry to free articles every month, plus you may customise what newsletters get delivered to your inbox every week, together with breaking information.

Source Link

What's Your Reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
View Comments (0)

Leave a Reply

Your email address will not be published.

2022 Blinking Robots.
WordPress by Doejo

Scroll To Top